Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer

Author:

Safavi Pegah1,Moghadam Kimia Behrouz2,Haghighi Zahra3,Ferns Gordon A.4,Rahmani Farzad35

Affiliation:

1. Department of Medical Radiation, Islamic Azad University, Science and Research Branch, Tehran, Iran

2. Department of Medicinal Chemistry, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

3. Department of Clinical Biochemistry, Kashmar School of Medical Sciences, Mashhad University of Medical Sciences, Mashhad, Iran

4. Division of Medical Education, Brighton & Sussex Medical School, Falmer, Brighton, Sussex BN1 9PH, UK

5. Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Abstract: Gynecologic cancers are among the most common malignancies with aggressive features and poor prognosis. Tumorigenesis in gynecologic cancers is a complicated process that is influenced by multiple factors, including genetic mutations that activate various oncogenic signaling pathways, including the TGF-β pathway. Aberrant activation of TGF-β signaling is correlated with tumor recurrence and metastasis. It has been shown that non-coding RNAs (ncRNAs) have crucial effects on cancer cell proliferation, migration, and metastasis. Upregulation of various ncRNAs, including long non-coding RNAs (lncRNA) and microRNAs (miRNAs), has been reported in several tumors, like cervical, ovarian, and endometrial cancers, but their cellular mechanisms remain to be investigated. Thus, recognizing the role of ncRNAs in regulating the TGF-β pathway may provide novel strategies for better treatment of cancer patients. The present study summarizes recent findings on the role of ncRNAs in regulating the TGF-β signaling involved in tumor progression and metastasis in gynecologic cancers.

Publisher

Bentham Science Publishers Ltd.

Reference98 articles.

1. Wahid M.; Dar S.A.; Jawed A.; Mandal R.K.; Akhter N.; Khan S.; Microbes in gynecologic cancers: Causes or consequences and therapeutic potential. Seminars in cancer biology 2022

2. Aboutalebi H.; Bahrami A.; Soleimani A.; Saeedi N.; Rahmani F.; Khazaei M.; Fiuji H.; Shafiee M.; Ferns G.A.; Avan A.; Hassanian S.M.; The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer. Int J Biochem Cell Biol 2020,124,105765

3. Faridnejad H.; The impact of physicochemical modification on iron oxide nanoparticle relaxation enhancement in biomedical imaging in the anticancer sector. Sch Res J 2022,10,26-33

4. Perelli F.; Mattei A.; Scambia G.; Cavaliere A.F.; Editorial: Methods in gynecological oncology. Front Oncol 2023,13,1167088

5. Armanpour S.; Malekzade S.; Maftooh M.; Tolou V.; Avan A.; Amerizadeh F.; Association of a genetic variant in the ATP-binding cassette sub-family B member 1 with risk of cervical cancer. Hum Genet 2022,34,201097

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3